Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Pinotti

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Journal of Thrombosis and Haemostasis : JTH|October 9, 2021
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypesAlessio Branchini, Massimo Morfini, Barbara Lunghi, et al.
Plos One|February 7, 2008
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosisNicola Martinelli, Elisabetta Trabetti, Mirko Pinotti, et al.
Cell Reports|April 14, 2021
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patientsGiampaolo Morciano, Gaia Pedriali, Massimo Bonora, et al.
Nature Communications|September 29, 2025
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional propertiesKristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, et al.
Science Translational Medicine|October 15, 2020
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologicsMalin Bern, Jeannette Nilsen, Mattia Ferrarese, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Journal of Thrombosis and Haemostasis : JTH|October 9, 2021
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypesAlessio Branchini, Massimo Morfini, Barbara Lunghi, et al.
Plos One|February 7, 2008
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosisNicola Martinelli, Elisabetta Trabetti, Mirko Pinotti, et al.
Cell Reports|April 14, 2021
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patientsGiampaolo Morciano, Gaia Pedriali, Massimo Bonora, et al.
Nature Communications|September 29, 2025
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional propertiesKristin Hovden Aaen, Maria Francesca Testa, Jeannette Nilsen, et al.
Science Translational Medicine|October 15, 2020
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologicsMalin Bern, Jeannette Nilsen, Mattia Ferrarese, et al.
Pageof 10